Public Health - Overdose and Infectious Disease Prevention Services Program
SB 83 authorizes community-based organizations (like clinics, health centers, or local health departments) to establish supervised overdose and infectious disease prevention programs in Maryland, subject to approval by the Maryland Department of Health. These programs must operate in high-drug-use areas (with a maximum of six total, distributed across urban, suburban, and rural zones) and provide services including sterile supplies, overdose response (including naloxone), HIV/hepatitis testing, referrals to treatment, and harm reduction education. Programs may bill insurance for covered services and use mobile facilities, but cannot be located in residential zones. The bill directly affects program operators, people who use drugs, and health insurers, focusing on reducing overdose and disease transmission through accessible, non-punitive services.
Bill status
in committee
1 of 4 stages cleared
Introduction
Sep 2024
Committee Review
Floor Vote
Governor
Introduced Sep 16, 2024
Last action Jan 22, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
1
Jan 8, 2025
Committee
First Reading Finance
upper
Sep 16, 2024
Introduced
Pre-filed
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Shelly Hettleman
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 83
Scope: MD
Hi! I can help you understand SB 83. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline